Bdfoie 4/Bdfoie 10 Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Bdfoie 4: White to off-white granular powder filled into size "4" hard gelatin capsules with opaque white cap and body.
Each hard gelatin capsule contains: Lenvatinib Mesylate 4.90 mg eq. to Lenvatinib 4.0 mg, Excipients q.s.
Approved colours used in capsule shells.
Bdfoie 10: White opaque/white opaque hard gelatin capsules size "01" containing white to off white granules.
Each hard gelatin capsule contains: Lenvatinib Mesylate 12.25 mg eq. to Lenvatinib 10 mg, Excipients q.s.
Approved colours used in capsule shells.

Bdfoie 4/Bdfoie 10 Description

lenvatinib

Manufacturer:

BDR Pharmaceuticals

Distributor:

Detoxicare

Marketer:

Ambica